Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.04 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $82.51 | 6 | $0 (2019) |
| Lilly USA, LLC | $39.46 | 3 | $0 (2018) |
| PFIZER INC. | $27.15 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $23.68 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $17.01 | 1 | $0 (2017) |
| Shire North American Group Inc | $15.41 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.54 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $11.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $27.55 | 2 | Novo Nordisk Inc ($27.55) |
| 2018 | $130.47 | 10 | Novo Nordisk Inc ($40.88) |
| 2017 | $70.02 | 5 | AstraZeneca Pharmaceuticals LP ($17.01) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 01/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
| 11/27/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Diabetes | ||||||
| 11/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 09/18/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, MENVEO | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: VACCINES | ||||||
| 07/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 06/07/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 04/19/2018 | PFIZER INC. | TRUMENBA (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: VACCINES | ||||||
| 01/25/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: VACCINES | ||||||
| 12/14/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Respiratory | ||||||
| 11/27/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 08/31/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.54 | General |
| 08/10/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 02/23/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 37 | $4,107 | $1,383 |
| 2022 | 2 | 39 | 56 | $6,150 | $1,815 |
| 2021 | 2 | 64 | 94 | $11,442 | $3,888 |
| 2020 | 6 | 236 | 297 | $29,220 | $11,656 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 37 | $4,107 | $1,383 | 33.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 45 | $4,995 | $1,231 | 24.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $1,155 | $584.39 | 50.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 42 | 70 | $7,770 | $1,960 | 25.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 22 | 24 | $3,672 | $1,927 | 52.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 50 | $8,128 | $2,961 | 36.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 75 | $7,848 | $2,896 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $3,325 | $2,164 | 65.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 33 | 58 | $6,330 | $1,773 | 28.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 20 | $3,004 | $1,650 | 54.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 58 | 73 | $585.00 | $211.74 | 36.2% |
About Dr. Jerad Widman, M.D
Dr. Jerad Widman, M.D is a Family Medicine healthcare provider based in Spring Hill, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083655039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerad Widman, M.D has received a total of $228.04 in payments from pharmaceutical and medical device companies, with $27.55 received in 2019. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($228.04).
As a Medicare-enrolled provider, Widman has provided services to 357 Medicare beneficiaries, totaling 484 services with total Medicare billing of $18,741. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Spring Hill, KS
- Active Since 06/09/2006
- Last Updated 10/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083655039
Products in Payments
- Ozempic (Drug) $68.43
- TRULICITY (Drug) $39.46
- SHINGRIX (Biological) $23.68
- SYMBICORT (Drug) $17.01
- MYDAYIS (Drug) $15.41
- Victoza (Drug) $14.08
- TRUMENBA (Biological) $13.59
- PREVNAR - 13 (Biological) $13.56
- XARELTO (Drug) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Spring Hill
Dr. Howard Farrington, Md, MD
Family Medicine — Payments: $16,362
Dr. Meghan Sills, M.d, M.D
Family Medicine — Payments: $9,923
Dr. Matthew Bowser, D.o, D.O
Family Medicine — Payments: $7,923
Kristien Polecritti, D.o, D.O
Family Medicine — Payments: $6,836
Dr. Sean Cannady, Do, DO
Family Medicine — Payments: $6,091
Nathanael Lafferty, M.d, M.D
Family Medicine — Payments: $6,010